GoodRx Holdings (GDRX) Receivables - Other (2020 - 2026)
GoodRx Holdings' (GDRX) quarterly Receivables - Other came in at $11.9 million in Q1 2026, little changed quarter-over-quarter from $11.9 million in Q4 2025.
GoodRx Holdings (GDRX) Receivables - Other (2020 - 2026) Analysis & Trends
GoodRx Holdings has disclosed Receivables - Other across 3 years of filings, most recently posting $11.9 million for Q1 2026.
- Receivables - Other for Q1 2026 came in at $11.9 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $11.9 million (changed N/A YoY), and the FY2025 annual result was $11.9 million, changed N/A from the prior year.
- Receivables - Other came in at $11.9 million for Q1 2026 at GoodRx Holdings, roughly flat from $11.9 million in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $11.9 million in Q4 2025 to a low of $11.9 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn |
| 10 | GoodRx Holdings | 909.22 Mn | 673.51 Mn | 112.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.90 Mn |
| Mar 31, 2026 | 11.90 Mn |
| Dec 31, 2025 | 11.90 Mn |
| Dec 31, 2025 | 11.90 Mn |
| Dec 31, 2020 | 5.70 Mn |
| Dec 31, 2020 | 5.70 Mn |